Respiratory News and Research

RSS

Cardiovascular mortality in schizophrenia may be underestimated

Cardiovascular causes account for about a quarter of deaths of patients with schizophrenia and may also contribute to the high rate of unexplained deaths, say researchers.

17 Sep 2013

Video demonstrates high throughput screening of cellular bioenergetics of multiple cell lines

INTEGRA has published a video demonstrating how its VIAFLO 96 handheld electronic pipette, used in conjunction with the Seahorse Bioscience XF96 Extracellular Flux Analyzer, provides high throughput screening of the cellular bioenergetics of multiple cell lines.

From INTEGRA Biosciences 17 Sep 2013

Attention drawn to COPD in never smokers

Research from Denmark shows that, while never smokers with chronic obstructive pulmonary disease typically experience milder disease than their smoking counterparts, they still have substantial morbidity due to COPD- and pneumonia-related hospital admissions.

16 Sep 2013

Phone support boost to COPD patients

Researchers from Australia have found that even brief phone contact from medical professionals can provide benefits to patients with chronic obstructive pulmonary disease.

16 Sep 2013

Sigma-Tau Pharmasource, Aradigm Ink Manufacturing Deal For Respiratory Disease Treatment

...

16 Sep 2013

Pew honors creative work on coronaviruses with biomedical researcher award

Cell biologist Carolyn Machamer, Ph.D is The Pew Charitable Trusts' biomedical researcher of the month for her creative work on coronaviruses. Specifically, Machamer studies how the family of viruses uses a host cell's machinery against it.

13 Sep 2013

$MatrixRIB MIPO instrumentation from DePuy Synthes CMF is more effective for rib fractures$

MatrixRIB MIPO instrumentation from DePuy Synthes CMF is more effective for rib fractures

DePuy Synthes CMF, a leader in skeletal and soft tissue repair and reconstruction, announced the launch of new instrumentation that enables less invasive surgical fixation and stabilization of rib fractures with the company's MatrixRIB System of precontoured, low-profile titanium plates, locking screws and intramedullary splints.

13 Sep 2013

Pertussis incidence among older adults may be under-recognized, study finds

The incidence of pertussis among U.S. adults 50 and older may be greatly under-reported and under-recognized, according to findings from a study conducted by GlaxoSmithKline researchers who analyzed approximately 48 million cases of cough-related illness in the U.S. between 2006 and 2010.

13 Sep 2013

Inhaled corticosteroids increase pneumonia risk in asthma

Research from the UK indicates that the use of inhaled corticosteroids is independently associated with an increased risk for pneumonia and lower respiratory tract infection in patients with asthma.

12 Sep 2013

Mold Count Exceeds 50,000 threshold in the Midwest, reports Gottlieb Allergy Count

If the unseasonable heat that is blanketing the Midwest doesn't affect area residents, the highest mold count for the 2013 allergy reporting season will. Gottlieb Allergy Count, the official allergy count for the Midwest, reports the mold count today is 85,000, a high for 2013, and well over the 50,000 threshold that signals a dangerous air quality warning.

12 Sep 2013

Asthma experts united to tackle Europe's high asthma prevalence and death rates

Asthma experts from across Europe are uniting as part of a new partnership launched this week to tackle Europe's high asthma prevalence and death rates.

12 Sep 2013

Hydroxyurea treatment prevents complications, lowers medical care costs in children sickle cell disease

The benefits of hydroxyurea treatment in people with sickle cell disease are well known -- fewer painful episodes, fewer blood transfusions and fewer hospitalizations. Now new research from the Johns Hopkins Children's Center and other institutions reveals that by preventing such complications, the drug can also considerably lower the overall cost of medical care in children with this condition.

12 Sep 2013

Researchers develop innovative system to test how virus interacts with cells in body

Researchers at The Mount Sinai Medical Center have developed an innovative system to test how a virus interacts with cells in the body — to see, for example, what happens in lung cells when a deadly respiratory virus attacks them.

12 Sep 2013

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

...

11 Sep 2013

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine’s efficacy in treating asthma patients and is not currently approved for this indication.

11 Sep 2013

Study suggests that social media can be used to successfully improve medical practice

Barcelona, Spain: A doctor from the UK has shown how an innovative music video can help increase awareness of how to treat asthma.

11 Sep 2013

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is deadly pneumonia that has killed more than 100 people, primarily in the Middle East.

10 Sep 2013

Astrazeneca, Hadasit Launch Drug Discovery Alliance

...

10 Sep 2013

Three rapid diagnostic tests could be used to diagnose drug resistance in TB

Results of a new study suggest that three new diagnostic tests could each be used to successfully diagnose drug resistance in tuberculosis (TB) patients in a quarter of the time taken by the current method.

10 Sep 2013

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.

10 Sep 2013

Respiratory News and Research

Cardiovascular mortality in schizophrenia may be underestimated

Video demonstrates high throughput screening of cellular bioenergetics of multiple cell lines

Attention drawn to COPD in never smokers

Phone support boost to COPD patients

Sigma-Tau Pharmasource, Aradigm Ink Manufacturing Deal For Respiratory Disease Treatment

Pew honors creative work on coronaviruses with biomedical researcher award

MatrixRIB MIPO instrumentation from DePuy Synthes CMF is more effective for rib fractures

Pertussis incidence among older adults may be under-recognized, study finds

Inhaled corticosteroids increase pneumonia risk in asthma

Mold Count Exceeds 50,000 threshold in the Midwest, reports Gottlieb Allergy Count

Asthma experts united to tackle Europe's high asthma prevalence and death rates

Hydroxyurea treatment prevents complications, lowers medical care costs in children sickle cell disease

Researchers develop innovative system to test how virus interacts with cells in body

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Study suggests that social media can be used to successfully improve medical practice

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Astrazeneca, Hadasit Launch Drug Discovery Alliance

Three rapid diagnostic tests could be used to diagnose drug resistance in TB

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News